Press release
Neuropathic Pain Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Neuropathic Pain Market
The expansion of the neuropathic pain market is expected to be propelled by the increasing occurrence of chronic pain. Chronic pain, which is ongoing and extends beyond the usual recovery period of an illness or injury, typically persists for at least three to six months. The surge in chronic pain, including neuropathic conditions, necessitates effective therapeutic approaches, which in turn stimulates research, innovation, and spending in the development of better treatment options for improving symptom management and the quality of life. For illustration, the Scottish Health Survey conducted in 2022 by the Scotland-based Scottish Government revealed that in 2022, over one-third (38%) of Scottish adults experienced pain or discomfort for three months or more. The prevalence of such conditions was higher among women (43%) than men (33%). So, the escalating prevalence of chronic pain is a factor generating the growth of the neuropathic pain market. The neuropathic pain market is likely to expand further due to the anticipated increase in diabetes cases. Diabetes, a chronic medical condition involving elevated blood glucose levels, often results in neuropathies, which are the most common long-term complications of diabetes, affecting over 50% of diabetics during their lifetime. Diabetic peripheral neuropathy (DPN) is the most common type of such neuropathies and has the best-established treatment methods. For example, data from the UK's National Health Service (NHS) in June 2024 indicated a significant increase in the number of individuals under 40 affected by diabetes, from 173,166 in 2022 to 216,440 in 2023. This sharp increase underlines a worrying trend among the younger population and a quick increase in diabetes prevalence. Therefore, the surge in diabetes cases is spurring the growth of the neuropathic pain market.
Get Your Neuropathic Pain Market Report Here:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
What is the projected compound annual growth rate (CAGR) of the neuropathic pain market from 2025 to 2034, and what factors influence it?
The market for neuropathic pain has been experiencing substantial growth in the past few years. The market, from being $5.35 billion in 2024, is projected to increase to $5.79 billion in 2025, marking an 8.2% compound annual growth rate (CAGR). The growth noted in the historical period resulted from a rise in the demand for drugs specialized for neuropathic pain, an escalating chronic pain epidemic, heightened demand for prescription-based treatments, and government initiatives.
The market for neuropathic pain is anticipated to witness substantial expansion in the coming years. It is projected to escalate to a value of $7.76 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The upswing throughout the forecast period is likely due to the increased understanding of neuropathic pain, an ever-growing elderly population, a robust healthcare landscape, and the ease of accessing treatments for neuropathic pain. Notable trends for the forecast period encompass superior diagnostic methods, advancements in pain control techniques, medical research improvements, approval of new medicines, and strategic approaches.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
How are the latest trends influencing the growth of the neuropathic pain market?
Leading firms in the neuropathic pain industry are utilizing artificial intelligence (AI) to provide innovative diagnosis, personalized treatment strategies, real-time assessment, pharmaceutical research, and data-informed perspectives to augment patient outcomes and optimize pain management methods. For instance, Nevro Corp., an American medical device company, in March 2023, introduced the Senza HFX iQ spinal cord stimulation (SCS) system. This cutting-edge technology employs AI to tailor pain relief to individual patients' needs. The system, encompassing the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, is constructed to address non-surgical back pain and painful diabetic neuropathy by adjusting to patients' feedback and responses. It utilizes a unique algorithm derived from comprehensive patient data and allows patients to alter their pain relief regimen using a smartphone app. The digital architecture of the system enables data gathering and possible updates. The technology aspires to improve pain relief through regularity and personalization, symbolizing a significant development in SCS therapy.
What are the major segments of the neuropathic pain market and their role in driving growth?
The neuropathic pain market covered in this report is segmented -
1) By Treatment: Medications, Multimodal Therapy
2) By Diagnosis: Imaging, Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications
4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Medications: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12922
Which regions are key players in the growth of the neuropathic pain market?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the neuropathic pain market?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp
What Is Covered In The Neuropathic Pain Global Market Report?
•Market Size Forecast: Examine the neuropathic pain market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the neuropathic pain market for a structured understanding.
•Key Players Overview: Analyze major players in the neuropathic pain market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the neuropathic pain market.
•Segment Contributions: Evaluate how different segments drive overall growth in the neuropathic pain market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the neuropathic pain market.
•Industry Challenges: Identify potential risks and obstacles affecting the neuropathic pain market.
•Competitive Landscape: Review strategic developments in the neuropathic pain market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3914793 • Views: …
More Releases from The Business Research Company
In-Depth Analysis of the Wind Market: Growth Opportunities, Key Trends, and Fore …
What Market Sizedynamics are playing a key role in accelerating the growth of the wind market?
The wind market's expansion is predicted to be driven by a burgeoning demand for renewable energy sources. These renewable power sources, which are replenished naturally over the human timescale without diminishing, are becoming more popular due to environmental considerations, political regulations, and climate objectives. Wind power plays a crucial role in renewable energy plans, offering…
A Deep Dive into Vitamin D Testing Market Size2025: Key Drivers, Growth Factors, …
Which drivers are expected to have the greatest impact on the over the vitamin d testing market's growth?
An increase in awareness about disorders originating from vitamin D deficiency is predicted to fuel the expansion of the vitamin D testing market. A vitamin D deficiency disorder is a health condition that arises when there is not enough vitamin D in the body, influencing calcium absorption adversely and causing problems like fragile…
Rising Neurodegenerative Disorders Fuel Growth In Vinpocetine Market SizeDriver: …
What industry-specific factors are fueling the growth of the vinpocetine market?
The upward trend in neurodegenerative condition cases is anticipated to boost the vinpocetine market's expansion. Neurodegenerative conditions involve a multitude of illnesses marked by the slow decay or death of nerve cells, known as neurons, in the brain or spinal cord. Numerous elements, including the growing elderly populace, unhealthy lifestyle choices, genetic predispositions, and environmental influences contribute to the escalating…
Impact of Rising Pet Ownership On The Growth Of The Veterinary Clinical Trials M …
What combination of drivers is leading to accelerated growth in the veterinary clinical trials market?
The veterinary clinical trials Market Sizeis poised for growth, driven by the increasing population of pet owners. Possessing and caring for one or more pets, referred to as pet ownership, is on the rise due to various reasons. These include the need for company, the therapeutic effects of pets, and enhanced understanding of their positive influence…
More Releases for Neuropathic
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Neuropathic Pain Market: Global Industry Demand, Market Future 2028
Neuropathic Pain Market
“Neuropathic Pain-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Neuropathic Pain epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
• Incidence and prevalence
• Diagnosis rate, treatment rate and mortality patterns
• Epidemiology-based forecasting and disease trends
• Size of different patient segments in a…
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.
Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.…
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot
Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most…
Neuropathic Pain Market Intelligence Report Offers Growth Prospects
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period.
The…
